The global raltegravir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Raltegravir comes under a class of medications called HIV integrase inhibitors. It binds and inhibits integrase, an HIV enzyme that inserts viral genetic material into the genetic material of the infected human cell. Treatment of HIV is one […]
